CeroSummer 2021Active☆Watch⊞Compare

Cero is one of 2138 Healthtech companies tracked from Santiago, Santiago Metropolitan Region, Chile; Remote, on record since 2021. By capital raised it ranks in the long tail (ahead of 8% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%

operates a technology-led product inferred from public copy

Grounded in: “You are a venture analyst”

Automated communication between hospitals and patients in Latam

At Cero, we solve specific coordination tasks between hospitals and patients, such as appointment confirmations and last minute cancellations, by automatically communicating with patients over WhatsApp. For example, a patient can confirm and reschedule their appointment without needing to call anyone. Almost half of the medical appointments in Latin America are missed because patients simply do not show up. This ranges from missing a regular dentist check to missing an expensive MRI scan. With increasing pressure to improve access to care in developing countries, optimizing communication and coordination with patients is a key task to achieve. This is a massive problem especially in places where most people don't know how to effectively use self-service mediums (or are too busy to use them). We bootstrapped the company and we are profitable. As of August 2021 we have $97K in monthly revenue from 15 clients with a CMRG of 20% in the last year. We have 100% logo retention and we grow with our clients. We are currently coordinating over 600,000 medical appointments every month, just in Chile. This problem represents a $3.5B market opportunity in Latin America only. Latin America has 650M people, each one having an average of 3 medical consultations per year. We charge for every time we effectively communicate with a patient. We plan to handle several coordination interactions with every patient for each consultation, which considers a roadmap of scheduling, confirming, booking, reimbursements, payments, among others. We are a team mixing strong knowledge about the healthcare industry with deep technical skills. Felipe (CEO) is a former dentist that has led deep changes in healthcare payments in Chile. Mauricio (CTO) and Jorge (R&D), both PhD in Computer Science, led the creation of the most advanced Spanish Language Neural Network used daily by scientists and practitioners in LatAm (BETO: Spanish BERT). In a weekend project, Mauricio and Jorge automated the communication with students attending a summer school obtaining impressive engagement. Felipe was struggling with contacting his patients to coordinate appointments, and saw a big opportunity in this technology. The three together have designed and run a solution that as of 2021 is coordinating over 600,000 patients per month in their home country, Chile.

As reported in public records reported — not modeled.

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

No round amounts on record to chart.

No staged rounds to sequence.

Round size and date are reported; the stage label is inferred from round size. Valuation is modeled from stage benchmarks. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Raised more than 8% of sector peers (real $). Modeled value above 8% of peers (estimate).

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Cero is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

See where Cero sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

If you work at Cero, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.